CClinicalTrials.gg
CompletedNCT04829591JoHFRUpdated Jul 19, 2024

A Multicenter Registry to Study the Characteristics and Outcomes of Jordanian Heart Failure Patients.

An observational study in Heart Failure, Chronic Heart Failure and Acute Heart Failure, sponsored by Jordan Cardio Vascular Research Group. Completed at 1 site in Jordan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-19.

Sponsored by Jordan Cardio Vascular Research Group · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,219
Ages
18 Years and older
Sex
All
01

Study summary

Heart Failure research registry is a collection of computerized information about individuals with heart failure. The database in this registry is obtained from several Jordanian medical centers which will represent an extremely valuable resource for epidemiological research on heart failure patients.

Read the detailed description

Understanding the cause of Heart Failure (HF) and how the body will respond to it, is critical for an effective treatment. HF is a global problem with significant morbidity and mortality, despite improved understanding of the pathophysiology and a growing range of therapeutic options. Jordanian Heart Failure Registry (JoHFR) will be the first research project of heart failure prevalence in Jordan. It is undertaken by primary healthcare professionals with main aim to improve knowledge about the care of patients with HF. The investigators responsible for conducting this research are physicians and their teams who deal with heart failure patients in their outpatient and inpatient clinic centers including the public and private medical sectors in Jordan's medical community. Standards in the Hashemite kingdom of Jordan complies with the recognized good guideline directed medical practices internationally

02

Conditions studied

  • Heart Failure
  • Chronic Heart Failure
  • Acute Heart Failure

Browse trials for

03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's enrollment of 2,219 is above the median of 200 across 1,679 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

This is the only study on the registry with Jordan Cardio Vascular Research Group as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients 18 years old and older with HF will be recruited from all over Jordan , resulting in an initial sample estimate of approximately 4000 patients.

Inclusion criteria

  1. Patients who are 18 years or older with Heart Failure diagnosis as defined by internationally recognized guidelines.
  2. Current residents of the Hashemite Kingdom of Jordan

Exclusion criteria

Exclusion Criteria:

  1. Patients who refuse or unable to sign a consent form.
  2. Patient inability to follow up with provider
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,219 participants (actual)
Patient registry
No

Interventions

  • Otherobservational

    Heart failure, non interventional

06

What researchers measure

Primary outcomes

  1. Cardiovascular death

    The main objective of the JoHFR is to obtain reliable estimate of rates of cardiovascular death and or hospitalization for decompensated heart failure

    Time frame: 12 months

Secondary outcomes

  1. worsening kidney function

    as compared to baseline eGFR

    Time frame: 12 months

07

Study locations

1 site
  • Farah Medical Campus
    Amman, 11180, Jordan
08

References and documents

Publications

  • Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G, Gomez-Mesa JE, Leong D, Ezekowitz J, Hage C, Lanas F, Maggioni AP, Sliwa K, Zhu J, Rouleau J, Balasubramanian K, Yusuf S; G-CHF Investigators. A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. Am Heart J. 2020 Sep;227:56-63. doi: 10.1016/j.ahj.2020.06.002. Epub 2020 Jun 6. PubMed 32679282 ↗
  • Savarese G, Vasko P, Jonsson A, Edner M, Dahlstrom U, Lund LH. The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure. Ups J Med Sci. 2019 Jan;124(1):65-69. doi: 10.1080/03009734.2018.1490831. Epub 2018 Aug 9. PubMed 30092697 ↗
  • Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, Ferrari R, Piepoli MF, Delgado Jimenez JF, Metra M, Fonseca C, Hradec J, Amir O, Logeart D, Dahlstrom U, Merkely B, Drozdz J, Goncalvesova E, Hassanein M, Chioncel O, Lainscak M, Seferovic PM, Tousoulis D, Kavoliuniene A, Fruhwald F, Fazlibegovic E, Temizhan A, Gatzov P, Erglis A, Laroche C, Mebazaa A; Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016 Jun;18(6):613-25. doi: 10.1002/ejhf.566. Erratum In: Eur J Heart Fail. 2017 Mar;19(3):438. doi: 10.1002/ejhf.772. PubMed 27324686 ↗
  • Bergethon KE, Ju C, DeVore AD, Hardy NC, Fonarow GC, Yancy CW, Heidenreich PA, Bhatt DL, Peterson ED, Hernandez AF. Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry. Circ Heart Fail. 2016 Jun;9(6):10.1161/CIRCHEARTFAILURE.115.002594 e002594. doi: 10.1161/CIRCHEARTFAILURE.115.002594. PubMed 27301467 ↗

Study documents

  • Study protocol · Apr 17, 2021
  • Informed consent form · Apr 17, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04829591
Lead sponsor
Jordan Cardio Vascular Research Group
Responsible party
Hadi Abu-Hantash (principle investigator and study chair, University of Jordan) — Principal investigator
First posted
Apr 2, 2021
Start date
Jul 1, 2021
Primary completion
Dec 30, 2023
Completion
Dec 30, 2023
Last update
Jul 19, 2024

Study contacts

Hadi M Abu-Hantash, MD,MSc
study chair · Interventional Cardiovascular Innovation group

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion